Our results revealed that knockdown of SLC25A39 significantly increased ROS level in CRC cells, while overexpression of SLC25A39 markedly decreased ROS level in CRC cells (Fig. 5A and B). Here, SLC25A39 is linked to colorectal carcinoma.